OTTAWA, Nov. 24, 2016 /CNW/ - The Government of Canada is supporting innovative researchprojects that have the power to dramatically improve the health of Canadians. Stem cells are being researched for the treatment of many conditions: spinal cord injuries, diabetes, arthritis, ALS, Parkinson's disease, Alzheimer's disease, macular degeneration
To support Canada's leading role in stem cell research and regenerative medicine, the Honourable Kirsty Duncan, Minister of Science, today announced $9 million for projects and clinical trials that will be funded through the Stem Cell Network (SCN). This funding is part of $12 million provided to the network in Budget 2016.
Canada is globally recognized as a leader in stem cell research with respect to patents, publications and collaboration. Regenerative medicine—harnessing the power of stem cells to repair, regenerate or replace damaged cells, tissues and organs affected by disease or illness—has emerged as a promising approach to disease prevention and treatment. In fact, stem cells have long been used to treat leukemia and other blood cancers and have tremendous potential to treat many other chronic, debilitating diseases that affect millions of Canadians every year.
The funding announced today supports 31 projects and clinical trials across Canada that are developing real-world therapies, products and treatments and are contributing to evidence-based policies on regenerative medicine.
"For years, Canadian researchers have been leaders in regenerative medicine. The funding announced today will support projects that encourage important partnerships between universities, hospitals and businesses so they may collaborate on bold, new stem cell technologies and health innovations that will improve the lives of Canadians. I am confident that, through the Stem Cell Network, Canadians are gaining a better understanding of this promising research, the results of which contribute to a strong and healthy population.– The Honourable Kirsty Duncan, Minister of Science
"We are a nation of leaders and innovators; it is in our DNA. The regenerative medicine research sector is fueled by stem cells and today it is at a tipping point, with the potential to see breakthroughs in our generation. I am thrilled that SCN is able to power the foundation of scientific excellence that exists within Canada's universities, research hospitals and institutes."– Dr. Michael Rudnicki, Scientific Director and CEO, Stem Cell Network
Prime Minister announces support to Canadian Centre for Advanced Therapeutic Cell Technologies
Follow Minister Duncan on social media.Twitter: @ScienceMinInstagram: sciencemin
SOURCE Innovation, Science and Economic Development Canada
Subscribe to our Free Newsletters!
Craniosynostosis is a condition where the bones of the skull are fused together prematurely ...
Episiotomy is a surgical incision made in the perineum between the vaginal orifice and the anus ...
Stickler syndrome is a rare genetic disorder which causes multisystem disorders predominantly ...View All